Evommune (EVMN) Earnings Date & Reports

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

EVMN is expected to report earnings to fall 12.36% to -77 cents per share on December 10

Q3'26

Est.

$-0.78

Q2'26

Missed

by $0.20

Q1'26

Beat

by $0.12

The last earnings report on August 07 showed earnings per share of -88 cents, missing the estimate of -68 cents. With 648.13K shares outstanding, the current market capitalization sits at 304.49M.

View a ticker or compare two or three

EVMN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for EVMN